Objective-To examine the relation between endothelial dependent and endothelial independent stimuli of varying intensity and measures of vascular function in the brachial artery of young healthy adults, to determine whether these responses are consistent and can be used to assess endothelial function. Design and setting-High resolution ultrasound was used to measure brachial artery diameter at rest, after reactive hyperaemia induced by forearm cuff occlusion, and after sublingual isosorbide dinitrate (ISDN). Each subject was assigned to a random order of six cuff occlusion times (30 seconds, 1.5, 2.5, 3.5, 4.5, and 8 minutes) and six doses of ISDN (10, 20, 50, 100, 200, and 400,ug 
Subjects-Three males and three females mean age 31 years (range 25 to 43) with no known risk factors for cardiovascular disease.
Main outcome measures-Flow mediated, endothelial dependent dilatation was compared to duration of cuff occlusion, peak reactive hyperaemia, and duration of increased flow. Nitrate induced, endothelial independent dilatation was compared to dose of ISDN and change in flow. Results-Vessel dilatation and duration of peak flow change increased with longer duration of cuff occlusion. After 4 5 minutes of occlusion, flow mediated dilatation was mean (SD) 96 (6)% of maximal response and did not increase significantly with longer occlusion times. No significant dilatation occurred after 10 (Heart 1997;78: [22] [23] [24] [25] [26] [27] Keywords: endothelium; vascular reactivity; atherogenesis Endothelial dysfunction plays a key part both in the pathophysiology of established coronary atherosclerosis and in the early stages of atherogenesis, before the onset of clinical disease.' -3 There is, therefore, increasing interest in the study of endothelial function in young subjects with cardiovascular risk factors4, to develop effective interventions at an early stage with the aim of altering the natural history of vascular disease.56 Strain gauge venous occlusion plethysmography has been used to study small vessel reactivity in response to pharmacological or physiological stimuli78 but is usually invasive and not able to examine large vessel physiology which is more relevant to vascular disease. We have developed a noninvasive high resolution ultrasound protocol to characterise endothelial dependent responses in the conduit arteries of the arm and leg.49 10 Tlhis compares dilatation to increased blood flow (an endothelial dependent response)3 following reactive hyperaemia induced by cuff inflation and deflation on the distal limb, with response to a sublingual nitrate, which is independent of endothelial function.
Impaired flow mediated dilatation has been shown in subjects as young as 7 years old with familial hypercholesterolaemia,9 in patients with insulin dependent diabetes, and in active'0 and passive cigarette smokers," suggesting early endothelial dysfunction. However, the relation between the intensity of the dilating stimulus (flow or nitrate) and the degree of vascular reactivity, which may influence interpretation of the biological significance of these experiments, has not been studied.
We examined the relation between dilatation of the brachial artery and differing duration of cuff occlusion (to influence the degree of flow increase) and isosorbide dinitrate (ISDN) doses, to establish the optimum duration of blood flow occlusion and nitrate dose to obtain maximum response to the two stimuli. This information will facilitate the use of this non-invasive measure of vascular function in serial studies of interventions designed to reverse early arterial damage.
Methods

SUBJECTS AND VISITrS
Six adult volunteers (three males and three females) with a mean age of 31 years (range 25 to 43) were recruited from our institution. All were normotensive, non-smokers, with normal serum cholesterol, no history of diabetes or family history of premature vascular disease, and none was receiving vasoactive medications.
Each subject underwent six separate vascular studies to assess brachial artery response to flow increase and ISDN. On each occasion on separate days they received one of six cuff occlusion times (30 seconds, 1-5, 2-5, 3 5, 4 5, and 8 minutes) and one of six sublingual ISDN doses (Isoket, Schwarz Pharma Ltd, Buckinghamshire, UK) (10 ,g, 20 jMg, 50 ,ug, 100 jMg, 200 Mg, and 400 pg). These studies were performed in a randomised order for each subject.
ULTRASOUND SCAN TECHNIQUE
Ultrasound scans were performed with subjects supine, at rest and the recorded room temperatures ranged from 20°C to 26GC.
Blood pressure was measured using a standard sphygmomanometer. On each visit, a B mode scan of the right brachial artery was obtained in longitudinal section between 5 cm and 10 cm above the elbow using a 7 0 MHz linear array transducer and a standard Acuson 128XP/10 system. The centre of the artery was identified when the clearest picture of the anterior and posterior intimal layers was obtained. The transducer was held at the same point on the upper arm throughout the scan, using a stereotactic clamp. The position of the transducer relative to the antecubital fossa was recorded on the first visit and the same point used at each subsequent scan. The transmit (focus) zone was set to the depth of the anterior wall of the right brachial artery. Depth and gain settings were set to optimise images of the lumen-arterial wall interface, images were magnified using a resolution box function, and operating parameters were not changed during the study. To measure arterial diameter the clearest defined section of the artery on B mode imaging was identified and an M mode cursor positioned over this point, at right angles to the arterial lumen. A five second segment of the A mode signal was then routed to a Wall Tracking System (Ingenious Systems, The Netherlands) which automatically tracks vessel wall movement on a beat by beat basis. The minimum arterial diameter was calculated from the distance between opposite lumen-arterial wall interfaces, as identified by manual selection of the maximal change in recorded radio frequency amplitude.'2-'4 Repeated measures in an individual using this system have been shown to be consistent and reproducible. 14 15 A resting scan was recorded, and arterial flow velocity measured using a pulsed Doppler signal at 70°to the vessel with the range gate (1-5 mm) in the centre of the artery. A pneumatic cuff, placed around the forearm distal to the imaged brachial artery segment, was then inflated to a pressure of 300 mm Hg for the length of time indicated by the study protocol. A second scan was taken continuously from 30 seconds before to 70 seconds after cuff release. This enabled flow velocity to be recorded for 10 seconds before and for 30 seconds after release, and a second measure of vessel diameter to be made between 55 and 65 seconds after cuff deflation. Ten minutes was allowed for vessel recovery, after which a second resting control scan and flow measurement was taken. ISDN was then administered according to the protocol and three minutes later a fourth scan of the vessel, with a final flow measurement, was recorded.
DATA ANALYSIS
The scans were assessed blindly from video tape playback and hard copy records of arterial diameter measurements. If the M mode cursor was not at the same point on the artery throughout the scan or if mean diameter measurements on the hard copy record had a variability of > 0-06 mm the whole study was discarded and repeated. The main outcome measure from the scans was flow mediated dilatation which is expressed as the percentage change in vessel diameter post hyperaemia. Similarly, response to ISDN was defined as the percentage change in diameter after ISDN.
Volume flow was calculated by multiplying the velocity time integral of the Doppler flow signal (corrected for angle) for a single pulse wave by the heart rate and vessel crosssectional area. The peak response to reactive hyperaemia was recorded as the maximum flow in a single cardiac cycle within the first 15 seconds after cuff deflation, divided by the flow during the resting (baseline) scan. Volume flow was also measured every five seconds for the 30 seconds immediately following forearm cuff deflation.
To examine dose response effects of length of cuff occlusion, the degree of flow mediated dilatation at eight minutes (the longest cuff occlusion time studied) was assumed to be maximal and the other flow mediated dilatations calculated as a percentage of the eight minute value. Similarly, dilatation after 400 Mg of ISDN was assumed to be maximal and values for other doses were expressed as a percentage of the response to 400 ,ug. To minimise the influence of age and sex equal numbers of male and female subjects of similar ages were studied (table) . Room temperature, time of day, body mass index, and vessel size were also similar within the group and did not appear to alter the vascular responses to flow and ISDN. We investigated the influence of cuff occlusion time and dose of ISDN on vessel diameter change and peak flow increase, and of cuff occlusion time on the volume of increased flow in the 15 seconds after cuff release.
Characteristics ofstudy group (mean (1 SD)) ,. Dose of isosorbide dinitrate (ig) Figure 6 Relation between dose of isosorbide dinitrate and endothelial independent dilatation (EID change only occurs after at least 4-5 minutes of cuff occlusion. The practical implication of these findings are that it is important to ensure a cuff time of 4 5 minutes to provoke a sustained flow increase and a reproducible maximum flow mediated dilatation and that higher cuff occlusion times do not provide greater response. Also, that peak reactive hyperaemia alone does not adequately define the intensity of stimulus causing vasodilatation. Nitrate containing drugs act as an exogenous source of nitric oxide to cause arterial smooth muscle relaxation directly, independent of the endothelium. 25 This study shows that response to sublingual ISDN is maximum after 200 jug and that higher doses do not produce greater dilatation. ISDN was used in this study instead of glyceryl trinitrate (our standard nitrate donating drug) because it was easier to dilute for the dose response study and more stable in lower concentrations.26 27 All ISDN concentrations used provide smaller nitrate doses than the single sublingual spray of glyceryl trinitrate we have reported previously28; however, the response to this stimulus in the same subjects is comparable to the maximal effect seen after 200 ug of ISDN. The submaximal 100 Mg dose of ISDN produces the equivalent degree of vasodilatation as the maximal endothelial dependent response. These results highlight the fact that the brachial artery has the potential to dilate more when stimulated by pharmacological doses of nitrate acting independently of the endothelium than following a physiological stimulus.
Loss of normal endothelial function may occur in young subjects and be an important pathogenic mechanism for the development of atherosclerosis. Endothelial derived nitric oxide is important in regulation of blood flow and inhibits platelet aggregation and monocyte adhesion. We used the non-invasive technique described in this study to demonstrate impaired flow mediated dilatation and relative preservation of response to glyceryl trinitrate, in preclinical subjects with a wide range of risk factors known to predispose to arterial disease in later life. The results now reported further support the interpretation of these findings that loss of flow mediated dilatation is due to a specific pathophysiological change in endothelial function. This non-invasive protocol, which is accurate and reproducible,28 has been shown to produce consistent physiological and pharmacological arterial responses and is ideal for evaluation of interventions designed to alter favourably the progression of arterial disease in young people. CPM 
